标题
Treatment of acromegaly in the era of personalized and predictive medicine
作者
关键词
-
出版物
CLINICAL ENDOCRINOLOGY
Volume 83, Issue 1, Pages 3-14
出版商
Wiley
发表日期
2015-02-02
DOI
10.1111/cen.12731
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Preoperative octreotide treatment of acromegaly: long-term results of a randomised controlled trial
- (2014) S L Fougner et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Frequency ofAIPGene Mutations in Young Patients With Acromegaly: A Registry-Based Study
- (2014) Christof Schöfl et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Stereotactic Radiosurgery for Acromegaly
- (2014) Cheng-Chia Lee et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly: An Endocrine Society Clinical Practice Guideline
- (2014) Laurence Katznelson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
- (2014) A. Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comparison of pegvisomant and long-acting octreotide in patients with acromegaly naïve to radiation and medical therapy
- (2014) E. Ghigo et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Expert consensus document: A consensus on the medical treatment of acromegaly
- (2014) Andrea Giustina et al. Nature Reviews Endocrinology
- The Truncated Isoform of Somatostatin Receptor5 (sst5TMD4) Is Associated with Poorly Differentiated Thyroid Cancer
- (2014) Manel Puig-Domingo et al. PLoS One
- Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial
- (2014) Mônica R Gadelha et al. Lancet Diabetes & Endocrinology
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly-2011 Update
- (2013) Laurence Katznelson et al. Endocrine Practice
- β-Arrestin 1 and 2 and G Protein-Coupled Receptor Kinase 2 Expression in Pituitary Adenomas: Role in the Regulation of Response to Somatostatin Analogue Treatment in Patients With Acromegaly
- (2013) Federico Gatto et al. ENDOCRINOLOGY
- Efficacy and Safety of an Octreotide Implant in the Treatment of Patients With Acromegaly
- (2013) Carla Chieffo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in Somatotroph Adenomas Assessed by Monoclonal Antibodies Was Reduced by Octreotide and Correlated With the Acute and Long-Term Effects of Octreotide
- (2013) Olivera Casar-Borota et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatments, complications, and healthcare utilization associated with acromegaly: a study in two large United States databases
- (2013) M. S. Broder et al. Pituitary
- Multiple facets in the control of acromegaly
- (2013) Lucio Vilar et al. Pituitary
- AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression
- (2012) Leandro Kasuki et al. ENDOCRINE-RELATED CANCER
- Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues
- (2012) Josep Oriola et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- No Evidence of a Detrimental Effect of Cabergoline Therapy on Cardiac Valves in Patients with Acromegaly
- (2012) Luigi Maione et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effective Combination Treatment with Cabergoline and Low-Dose Pegvisomant in Active Acromegaly: A Prospective Clinical Trial
- (2012) C. E. Higham et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Oral Octreotide Absorption in Human Subjects: Comparable Pharmacokinetics to Parenteral Octreotide and Effective Growth Hormone Suppression
- (2012) S. Tuvia et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Somatostatin Analogs Modulate AIP in Somatotroph Adenomas: The Role of the ZAC1 Pathway
- (2012) Harvinder S. Chahal et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Real-world comorbidities and treatment patterns of patients with acromegaly in two large US health plan databases
- (2012) Tanya Burton et al. Pituitary
- A consensus on the diagnosis and treatment of acromegaly complications
- (2012) S. Melmed et al. Pituitary
- The OASIS study: Therapeutic management of acromegaly in standard clinical practice. Assessment of the efficacy of various treatment strategies
- (2012) Manuel Luque-Ramírez et al. Endocrinologia y Nutricion
- Epidemiología de la acromegalia en España
- (2012) Gemma Sesmilo Endocrinologia y Nutricion
- Acromegaly surgery in Manchester revisited - The impact of reducing surgeon numbers and the 2010 consensus guidelines for disease remission
- (2011) Yi Yuen Wang et al. CLINICAL ENDOCRINOLOGY
- Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly
- (2011) Ansgar Heck et al. CLINICAL ENDOCRINOLOGY
- Differential expression of genes related to drug responsiveness between sparsely and densely granulated somatotroph adenomas
- (2011) Masako Kato et al. ENDOCRINE JOURNAL
- Resistance to Somatostatin Analogs in Acromegaly
- (2011) Annamaria Colao et al. ENDOCRINE REVIEWS
- DG3173 (somatoprim), a unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reduces GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumours
- (2011) U Plöckinger et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Growth Hormone Receptor Variants and Response to Pegvisomant in Monotherapy or in Combination with Somatostatin Analogs in Acromegalic Patients: A Multicenter Study
- (2011) M. Filopanti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of presurgical long-acting octreotide treatment in acromegaly patients with invasive pituitary macroadenomas: a prospective randomized study
- (2010) Ming Shen et al. ENDOCRINE JOURNAL
- Magnetic Resonance Imaging as a Predictor of Response to Somatostatin Analogs in Acromegaly after Surgical Failure
- (2010) Manel Puig-Domingo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Potential Inhibitory Role for the New Truncated Variant of Somatostatin Receptor 5, sst5TMD4, in Pituitary Adenomas Poorly Responsive to Somatostatin Analogs
- (2010) Mario Durán-Prado et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Expression of E-Cadherin in Somatotroph Pituitary Adenomas Is Related to Tumor Size, Invasiveness, and Somatostatin Analog Response
- (2010) Stine Lyngvi Fougner et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The value of an acute octreotide suppression test in predicting response to long-term somatostatin analogue therapy in patients with acromegaly
- (2010) TR Bandgar et al. Journal of Postgraduate Medicine
- Pharmacological management of acromegaly: a current perspective
- (2010) Sunil Manjila et al. Neurosurgical Focus
- Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas
- (2010) Beverly MK Biller et al. BMC Endocrine Disorders
- Long-term treatment of acromegalic patients resistant to somatostatin analogues with the GH receptor antagonist pegvisomant: its efficacy in relation to gender and previous radiotherapy
- (2009) Mónica Marazuela et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Effects of Somatostatin Analogs on Glucose Homeostasis: A Metaanalysis of Acromegaly Studies
- (2009) Gherardo Mazziotti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Guidelines for Acromegaly Management: An Update
- (2009) S. Melmed et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Exon 3-Deleted Growth Hormone Receptor Is Associated with Better Response to Pegvisomant Therapy in Acromegaly
- (2009) Ignacio Bernabeu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly pathogenesis and treatment
- (2009) Shlomo Melmed JOURNAL OF CLINICAL INVESTIGATION
- Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide
- (2008) N. Karavitaki et al. CLINICAL ENDOCRINOLOGY
- A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly
- (2008) I M Holdaway et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Quantitative analysis of somatostatin receptor subtypes (1–5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR
- (2008) Giselle F Taboada et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- A Short Acute Octreotide Test for Response Prediction of Long-term Treatment with Somatostatin Analogues in Acromegalic Patients
- (2008) I. Halperin et al. HORMONE AND METABOLIC RESEARCH
- Does Preoperative Somatostatin Analog Treatment Improve Surgical Cure Rates in Acromegaly? A New Look at an Old Question
- (2008) Albert Beckers JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Correlation ofin Vitroandin VivoSomatotropic Adenoma Responsiveness to Somatostatin Analogs and Dopamine Agonists with Immunohistochemical Evaluation of Somatostatin and Dopamine Receptors and Electron Microscopy
- (2008) Diego Ferone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Low Levels of Raf Kinase Inhibitory Protein in Growth Hormone-Secreting Pituitary Adenomas Correlate with Poor Response to Octreotide Treatment
- (2008) Stine Lyngvi Fougner et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Selective Loss of Somatostatin Receptor 2 in Octreotide-Resistant Growth Hormone-Secreting Adenomas
- (2008) Ursula Plöckinger et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Differential Effects of Octreotide and Pasireotide on Somatostatin Receptor Internalization and Traffickingin Vitro
- (2008) Sarah Lesche et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in neuroendocrine tumors
- (2007) Tullio Florio Frontiers in Bioscience-Landmark
- Mortality in Acromegaly: A Metaanalysis
- (2007) O. M. Dekkers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started